“Harnessing Nanoemulsion Technology for Enhanced Delivery of Canagliflozin in Type 2 Diabetes Therapy”. Asian Journal of Pharmaceutics (AJP) 19, no. 2 (July 23, 2025). Accessed April 14, 2026. http://www.asiapharmaceutics.info/index.php/ajp/article/view/6497.